Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Brain Research|March 19, 1993
Neuroprotective activity of dimer of 16,16'-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemiaR C Lin, D F Matesic, R J McKenzie, et al.
European Journal of Pharmacology|August 14, 1992
A novel treatment of global cerebral ischaemia with a glycine partial agonistD K Von Lubitz, R C Lin, R J McKenzie, et al.
European Journal of Pharmacology|May 4, 1999
Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonistD K Von Lubitz, R C Lin, N Bischofberger, et al.
European Journal of Pharmacology|April 21, 1994
Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemiaD K Von Lubitz, R C Lin, N Melman, et al.
European Journal of Pharmacology|December 5, 1996
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbilsD K Von Lubitz, R C Lin, I A Paul, et al.
Molecular Pharmacology|December 1, 1995
G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brainM P Abbracchio, R Brambilla, S Ceruti, et al.
European Journal of Pharmacology|February 24, 1995
The effects of adenosine A3 receptor stimulation on seizures in miceD K Von Lubitz, M F Carter, S I Deutsch, et al.
European Journal of Pharmacology|April 29, 1996
Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonistD K Von Lubitz, M Beenhakker, R C Lin, et al.
European Journal of Pharmacology|September 5, 1995
Chronic NMDA receptor stimulation: therapeutic implications of its effect on adenosine A1 receptorsD K Von Lubitz, J Kim, M Beenhakker, et al.
Pageof 3